In 2023, the number of transurethral prostatectomy procedures performed in Canada stood at approximately 17.33 thousand inpatient cases. Forecasted data indicates a gradual decline over the next five years: 17.29 thousand in 2024, 17.25 thousand in 2025, 17.22 thousand in 2026, 17.18 thousand in 2027, and 17.15 thousand in 2028. The year-on-year decline between 2024 and 2025 is around 0.23%, with similar trends continuing yearly. The overall compound annual growth rate (CAGR) from 2024 to 2028 reflects an average yearly decrease of 0.20%.
Future trends to watch for include potential impacts of advancing minimally invasive technologies and alternative therapies, which could further reduce demand for traditional surgical procedures. An increase in prostate health awareness and early diagnosis might also influence procedure volumes.
